Lyme Patient Advocates Document Misinformation Campaign by IDSA Guidelines Panelists
Hundreds of thousands of chronically ill patients are harmed by the dissemination of propaganda and suppression of relevant science, which, regardless of intent, amounts to scientific fraud.
The Patient Centered Care Advocacy (PCC) Group says it has documented a deliberate misinformation campaign by Infectious Diseases Society of America (IDSA) panelists who are tasked with updating IDSA’s guidelines for Lyme disease.
The PCC Group cites the article Lyme Guidelines Panelists Engage in Coordinated Propaganda Campaign, by Bruce Fries of the Mayday Project. The article claims to provide detailed evidence about a propaganda campaign by the Ad Hoc International Lyme Disease Group. According to an analysis of CDC (US Centers for Disease Control and Prevention) emails obtained via a FOIA request, the Ad Hoc group has been covertly setting government policy on Lyme disease and misinforming the public about the disease for the past decade.
Fries noted, “Rather than advancing scientific knowledge and making information available that could help patients restore their health, IDSA panelists suppress good science and withhold relevant information from patients, colleagues, and the public.”
Since they were first published in 2000, the IDSA guidelines for Lyme disease have been the subject of intense controversy, including an antitrust investigation.
Debate focuses on the existence of chronic Lyme disease, also referred to as “persistent infection,” meaning some Lyme bacteria tolerate and survive antibiotic treatment.
The view enforced by IDSA is that Lyme disease is easy to diagnose and simple to treat with a limited course of antibiotics. According to the IDSA guidelines, chronic Lyme does not exist and long-term antibiotic treatment is not warranted. Many physicians adhere to the IDSA guidelines and insurance companies use the guidelines to set coverage limits.
The International Lyme and Associated Diseases Society (ILADS) maintains Lyme disease is a serious national medical problem of epidemic proportion. The ILADS guidelines recognize chronic Lyme and recommend that the “duration of therapy be guided by clinical response, rather than by an arbitrary treatment course.”
Hundreds of peer-reviewed articles now support the ILADS position. These articles document many ways that Lyme bacteria can evade the immune system and survive antibiotic treatment.
According to Fries, “Hundreds of thousands of chronically ill patients are harmed by the dissemination of propaganda and suppression of relevant science, which, regardless of intent, amounts to scientific fraud.”
Patients and advocates will make their voices heard during a protest and vigil October 9 – 10 at IDSA’s IDWeek conference in San Diego.
( Press Release Image: http://photos.webwire.com/prmedia/48616/200341/200341-1.jpg )
- Contact Information
- Jen Willems
- Media Relations
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.